Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163
Open Access
- 1 February 2005
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (2) , 321-324
- https://doi.org/10.1136/ard.2003.018382
Abstract
Background: Crohn’s disease is associated with an increased number of macrophages in ileal and colonic mucosa. Data on macrophages in gut mucosa of patients with spondyloarthritis (SpA) are scarce. Objective: To investigate macrophages and other antigen presenting cells in gut mucosa from patients with SpA and Crohn’s disease, given the relationship between both entities. Methods: Biopsy specimens from patients with SpA, Crohn’s disease, ulcerative colitis, and from controls were immunohistochemically stained with different markers for macrophages and dendritic cells. Slides were scored semiquantitatively on a four point scale. Results: SpA and Crohn’s disease were associated with large numbers of CD68+ macrophages. Colon mucosa of both patients with SpA and Crohn’s disease, but not ulcerative colitis, showed increased numbers of macrophages expressing the scavenger receptor CD163. Conclusions: Macrophages expressing the scavenger receptor CD163 are increased in colonic mucosa in SpA and in Crohn’s disease, highlighting the relationship between these entities. The increased number of CD163+ macrophages in colon mucosa of patients with SpA suggests this is another argument for a role of macrophage scavenger receptors in this group of diseases.Keywords
This publication has 15 references indexed in Scilit:
- Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathyArthritis & Rheumatism, 2002
- Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathyThe Journal of Pathology, 2002
- The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndromeClinical and Experimental Immunology, 2001
- Expression of host defense scavenger receptors in spondylarthropathyArthritis & Rheumatism, 2001
- Identification of the haemoglobin scavenger receptorNature, 2001
- Antibodies to tumour necrosis factor α as treatment for Crohn's diseaseThe Lancet, 2000
- Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis & Rheumatism, 1995
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Intestinal fine structure in crohn's diseaseVirchows Archiv, 1981